Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Common Stock | Options Exercise | $0 | +11.9K | +4.38% | $0.00 | 283K | Jun 4, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Restricted Stock Units | Options Exercise | $0 | -11.9K | -100% | $0.00* | 0 | Jun 4, 2024 | Common Stock | 11.9K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding and unvested equity totaling 11, 904 shares of common stock. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. |